These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins. Serhan CN; Chiang N ScientificWorldJournal; 2002 Jan; 2():169-204. PubMed ID: 12806051 [TBL] [Abstract][Full Text] [Related]
9. Mutations of serine 236-237 and tyrosine 302 residues in the human lipoxin A4 receptor intracellular domains result in sustained signaling. Kang Y; Taddeo B; Varai G; Varga J; Fiore S Biochemistry; 2000 Nov; 39(44):13551-7. PubMed ID: 11063592 [TBL] [Abstract][Full Text] [Related]
10. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. Mitchell S; Thomas G; Harvey K; Cottell D; Reville K; Berlasconi G; Petasis NA; Erwig L; Rees AJ; Savill J; Brady HR; Godson C J Am Soc Nephrol; 2002 Oct; 13(10):2497-507. PubMed ID: 12239238 [TBL] [Abstract][Full Text] [Related]
11. Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells. Ariel A; Chiang N; Arita M; Petasis NA; Serhan CN J Immunol; 2003 Jun; 170(12):6266-72. PubMed ID: 12794159 [TBL] [Abstract][Full Text] [Related]
12. Aspirin-triggered 15-epi-lipoxin A4 and stable analogs on lipoxin A4 are potent inhibitors of acute inflammation. Receptors and pathways. Serhan CN; Takano T; Maddox JF Adv Exp Med Biol; 1999; 447():133-49. PubMed ID: 10086190 [No Abstract] [Full Text] [Related]
13. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Perretti M; Chiang N; La M; Fierro IM; Marullo S; Getting SJ; Solito E; Serhan CN Nat Med; 2002 Nov; 8(11):1296-302. PubMed ID: 12368905 [TBL] [Abstract][Full Text] [Related]
14. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Serhan CN Prostaglandins; 1997 Feb; 53(2):107-37. PubMed ID: 9112289 [TBL] [Abstract][Full Text] [Related]
15. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Chiang N; Serhan CN; Dahlén SE; Drazen JM; Hay DW; Rovati GE; Shimizu T; Yokomizo T; Brink C Pharmacol Rev; 2006 Sep; 58(3):463-87. PubMed ID: 16968948 [TBL] [Abstract][Full Text] [Related]
16. Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases. Pouliot M; Serhan CN J Periodontal Res; 1999 Oct; 34(7):370-3. PubMed ID: 10685363 [TBL] [Abstract][Full Text] [Related]
17. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. József L; Zouki C; Petasis NA; Serhan CN; Filep JG Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13266-71. PubMed ID: 12235371 [TBL] [Abstract][Full Text] [Related]
18. Lipoxins, aspirin-triggered 15-epi-lipoxin stable analogs and their receptors in anti-inflammation: a window for therapeutic opportunity. Serhan CN; Levy BD; Clish CB; Gronert K; Chiang N Ernst Schering Res Found Workshop; 2000; (31):143-85. PubMed ID: 10943332 [TBL] [Abstract][Full Text] [Related]
19. A novel rat lipoxin A4 receptor that is conserved in structure and function. Chiang N; Takano T; Arita M; Watanabe S; Serhan CN Br J Pharmacol; 2003 May; 139(1):89-98. PubMed ID: 12746227 [TBL] [Abstract][Full Text] [Related]
20. Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation. El Kebir D; József L; Filep JG J Leukoc Biol; 2008 Sep; 84(3):600-6. PubMed ID: 18495783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]